Epi Vax Therapeutics, Inc. announced it raised $370,000 in an initial filing from an offering of $370,000

Feb 22, 2021•over 4 years ago

Amount Raised

$370,000

Round Type

seed

ProvidenceBiotechnology

Company Information

Company

EpiVax Therapeutics, Inc.

Location

188 Valley Street

Providence, Rhode Island, United States

About

EpiVax Therapeutics ('EVT'), an emerging biotechnology startup founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Epi Vax Therapeutics, Inc. announced it raised $370,000 in an initial filing from an offering of $370,000

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information